SCFAs directly cross the blood–brain barrier and act on the central nervous system to regulate redox enzymes, activate the Nrf2 pathway, and maintain redox homeostasis under physiological conditions, thereby preventing Aβ accumulation and ameliorating cognitive impairment [11,63]. The gene discussed is NFE2L2; the disease is Cognitive impairment.